{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:32:57Z","timestamp":1777948377323,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017536","name":"Shanghai Pulmonary Hospital","doi-asserted-by":"publisher","award":["L22-357"],"award-info":[{"award-number":["L22-357"]}],"id":[{"id":"10.13039\/501100017536","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21DZ2201900"],"award-info":[{"award-number":["21DZ2201900"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cllc.2025.02.009","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:05:50Z","timestamp":1740168350000},"page":"393-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predicting Severe Radiation Pneumonitis in Patients With Locally-Advanced Non\u2013Small-Cell Lung Cancer After Thoracic Radiotherapy: Development and Validation of a Nomogram Based on the Clinical, Hematological, and Dose-Volume Histogram Parameters"],"prefix":"10.1016","volume":"26","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei-Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Shuai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Jing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang-Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Ren","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.cllc.2025.02.009_bib0002","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.cllc.2025.02.009_bib0003","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: a population-based study","volume":"24","author":"Zhang","year":"2023","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.cllc.2025.02.009_bib0004","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Auperin","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.cllc.2025.02.009_bib0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.6004\/jnccn.2023.0020","article-title":"NCCN Guidelines(R) insights: non-small cell lung cancer, version 2.2023","volume":"21","author":"Ettinger","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-020-01376-4","article-title":"Radiation-induced lung injury: current evidence","volume":"21","author":"Arroyo-Hernandez","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0007","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1038\/s41598-021-85131-7","article-title":"A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer","volume":"11","author":"Or","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.cllc.2025.02.009_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2004.02.015","article-title":"Prediction of radiation pneumonitis by dose\u2013volume histogram parameters in lung cancer\u2014a systematic review","volume":"71","author":"Rodrigues","year":"2004","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0009","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13014-017-0891-z","article-title":"Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis","volume":"12","author":"Uchida","year":"2017","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2025.02.009_bib0010","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","article-title":"Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis","volume":"85","author":"Palma","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.cllc.2025.02.009_bib0011","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/cancers10070222","article-title":"Radiation pneumonitis: old problem, new tricks","volume":"10","author":"Jain","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0012","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12967-023-04212-5","article-title":"Re-evaluating the risk factors for radiation pneumonitis in the era of immunotherapy","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.cllc.2025.02.009_bib0013","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccm.2016.12.004","article-title":"Radiation pneumonitis","volume":"38","author":"Bledsoe","year":"2017","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1016\/j.cllc.2025.02.009_bib0014","doi-asserted-by":"crossref","first-page":"307","DOI":"10.21037\/tlcr-22-108","article-title":"Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review","volume":"11","author":"Yan","year":"2022","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.cllc.2025.02.009_bib0015","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5. U.S. Department of Health and Human Services. National Institutes of Health National Cancer Institute. 2017."},{"key":"10.1016\/j.cllc.2025.02.009_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.lungcan.2022.07.005","article-title":"Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis","volume":"171","author":"Sugimoto","year":"2022","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.cllc.2025.02.009_bib0017","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.adro.2019.08.010","article-title":"Fatal radiation pneumonitis: literature review and case series","volume":"5","author":"Keffer","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0018","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2006.06.007","article-title":"Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients","volume":"80","author":"Sekine","year":"2006","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-8140(98)00064-4","article-title":"Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients","volume":"49","author":"Johansson","year":"1998","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2025.02.009_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2004.02.005","article-title":"A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis","volume":"71","author":"Claude","year":"2004","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.cllc.2025.02.009_bib0021","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1378\/chest.11-1193","article-title":"Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy","volume":"141","author":"Takeda","year":"2012","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.cllc.2025.02.009_bib0022","first-page":"XC01","article-title":"Radiation pneumonitis after conventional radiotherapy for breast cancer: a prospective study","volume":"9","author":"Jeba","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"5","key":"10.1016\/j.cllc.2025.02.009_bib0023","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.prro.2016.01.009","article-title":"Severe radiation pneumonitis after lung stereotactic ablative radiation therapy in patients with interstitial lung disease","volume":"6","author":"Bahig","year":"2016","journal-title":"Pract Radiat Oncol"},{"issue":"3 Suppl","key":"10.1016\/j.cllc.2025.02.009_bib0024","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose-volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.cllc.2025.02.009_bib0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/JTO.0000000000000187","article-title":"Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer","volume":"9","author":"Tsujino","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0026","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2009.01.036","article-title":"Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy","volume":"76","author":"Ramella","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/0284186X.2010.521192","article-title":"Heart irradiation as a risk factor for radiation pneumonitis","volume":"50","author":"Huang","year":"2011","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.cllc.2025.02.009_bib0028","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jtho.2023.04.008","article-title":"Korean real-world data on patients with unresectable stage III NSCLC treated with durvalumab after chemoradiotherapy","volume":"18","author":"Park","year":"2023","journal-title":"PACIFIC-KR. J Thorac Oncol."},{"key":"10.1016\/j.cllc.2025.02.009_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.898653","article-title":"Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy","volume":"12","author":"Qiu","year":"2022","journal-title":"Front Oncol"},{"issue":"20","key":"10.1016\/j.cllc.2025.02.009_bib0030","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cllc.2025.02.009_bib0031","first-page":"e25665","article-title":"Comparison of pneumonitis rates and severity in patients with lung cancer treated by immunotherapy, radiotherapy, and immunoradiotherapy","volume":"14","author":"Aiad","year":"2022","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.cllc.2025.02.009_bib0032","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/j.cllc.2020.02.025","article-title":"Immune-related pneumonitis after chemoradiotherapy and subsequent immune checkpoint blockade in unresectable stage III non-small-cell lung cancer","volume":"21","author":"Naidoo","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"10.1016\/j.cllc.2025.02.009_bib0033","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung Cancer, version 4.2024","volume":"22","author":"Riely","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.cllc.2025.02.009_bib0034","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/pro6.1169","article-title":"Chinese expert consensus on diagnosis and treatment of radiation pneumonitis","volume":"6","author":"zhou","year":"2022","journal-title":"Precis Radiat Oncol"},{"key":"10.1016\/j.cllc.2025.02.009_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2018.10.016","article-title":"Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: development and internal validation of a nomogram based on the clinical and dose-volume histogram parameters","volume":"132","author":"Tang","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2025.02.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211026671","article-title":"Construction and verification of a radiation pneumonia prediction model based on multiple parameters","volume":"28","author":"Yafeng","year":"2021","journal-title":"Cancer Control"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0037","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13014-023-02304-6","article-title":"Analysis of clinical and physical dosimetric factors that determine the outcome of severe acute radiation pneumonitis in lung cancer patients","volume":"18","author":"Zhao","year":"2023","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0038","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0360-3016(00)00648-9","article-title":"Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer","volume":"48","author":"Robnett","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2025.02.009_bib0039","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1748-717X-5-35","article-title":"Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"5","author":"Shi","year":"2010","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.cllc.2025.02.009_bib0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2009.06.001","article-title":"Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors","volume":"77","author":"Takeda","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.cllc.2025.02.009_bib0041","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ijrobp.2023.09.050","article-title":"Pneumonitis after chemoradiotherapy and adjuvant durvalumab in stage III non-small cell lung cancer","volume":"118","author":"Edwards","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.cllc.2025.02.009_bib0042","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1007\/s00432-023-04827-7","article-title":"A multiomics approach-based prediction of radiation pneumonia in lung cancer patients: impact on survival outcome","volume":"149","author":"Niu","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0043","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13014-018-1030-1","article-title":"Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy","volume":"13","author":"Li","year":"2018","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0044","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13014-021-01798-2","article-title":"Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy","volume":"16","author":"Li","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.cllc.2025.02.009_bib0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2021.05.026","article-title":"Radiation pneumonitis after palliative radiotherapy in cancer patients with interstitial lung disease","volume":"161","author":"Okumura","year":"2021","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.cllc.2025.02.009_bib0046","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.21037\/jtd.2018.05.75","article-title":"Lung cancer and interstitial lung disease: a literature review","volume":"10","author":"Naccache","year":"2018","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.cllc.2025.02.009_bib0047","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jtcvs.2017.04.029","article-title":"Interstitial lung disease and lung cancer: decisions, precision, and tuna fish sandwiches","volume":"154","author":"Ferraris","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.cllc.2025.02.009_bib0048","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/S0003-4975(03)00966-4","article-title":"Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication?","volume":"76","author":"Fujimoto","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0049","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/2278-330X.126503","article-title":"Ipsilateral lung dose volume parameters predict radiation pneumonitis in addition to classical dose volume parameters in locally advanced NSCLC treated with combined modality therapy","volume":"3","author":"Agrawal","year":"2014","journal-title":"South Asian J Cancer"},{"issue":"8","key":"10.1016\/j.cllc.2025.02.009_bib0050","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jtho.2023.04.008","article-title":"Korean real-world data on patients with unresectable stage III NSCLC treated with Durvalumab after chemoradiotherapy: PACIFIC-KR","volume":"18","author":"Park","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2025.02.009_bib0051","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/JHC.S334933","article-title":"Dynamic changes in neutrophil-to-lymphocyte ratio are associated with survival and liver toxicity following stereotactic body radiotherapy for hepatocellular carcinoma","volume":"8","author":"Hsiang","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"10.1016\/j.cllc.2025.02.009_bib0052","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.radonc.2017.08.023","article-title":"The prognostic value of derived neutrophil to lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy","volume":"125","author":"Cox","year":"2017","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.cllc.2025.02.009_bib0053","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7326\/0003-4819-109-4-288","article-title":"Radiation-induced lung injury: a hypersensitivity pneumonitis?","volume":"109","author":"Gibson","year":"1988","journal-title":"Ann Intern Med"},{"issue":"20","key":"10.1016\/j.cllc.2025.02.009_bib0054","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1158\/1078-0432.CCR-04-2634","article-title":"CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients","volume":"11","author":"Ozsahin","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.cllc.2025.02.009_bib0055","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.clon.2018.08.006","article-title":"Risk of death from pneumocystis jirovecii after curative-intent radiotherapy for lung cancer","volume":"30","author":"McAleese","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"20","key":"10.1016\/j.cllc.2025.02.009_bib0056","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.21037\/atm-20-6484","article-title":"Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study","volume":"8","author":"Hu","year":"2020","journal-title":"Ann Transl Med"},{"issue":"10","key":"10.1016\/j.cllc.2025.02.009_bib0057","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1002\/cam4.2987","article-title":"Early variations in lymphocytes and T lymphocyte subsets are associated with radiation pneumonitis in lung cancer patients and experimental mice received thoracic irradiation","volume":"9","author":"Zhou","year":"2020","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.cllc.2025.02.009_bib0058","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jtho.2020.06.008","article-title":"Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer","volume":"15","author":"Abravan","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2025.02.009_bib0059","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3389\/fimmu.2017.00506","article-title":"Immunological aspect of radiation-induced pneumonitis, current treatment strategies, and future prospects","volume":"8","author":"Kainthola","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.cllc.2025.02.009_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110261","article-title":"Synergizing the interaction of single nucleotide polymorphisms with dosiomics features to build a dual-omics model for the prediction of radiation pneumonitis","volume":"196","author":"Liang","year":"2024","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.cllc.2025.02.009_bib0061","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2021.01.018","article-title":"The plasma levels and polymorphisms of vitronectin predict radiation pneumonitis in patients with lung cancer receiving thoracic radiation therapy","volume":"110","author":"Yu","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:29:30Z","timestamp":1777793370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730425000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1525730425000427"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2025.02.009","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Severe Radiation Pneumonitis in Patients With Locally-Advanced Non\u2013Small-Cell Lung Cancer After Thoracic Radiotherapy: Development and Validation of a Nomogram Based on the Clinical, Hematological, and Dose-Volume Histogram Parameters","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2025.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}